![VJHemOnc Podcast](https://pbcdn1.podbean.com/imglogo/image-logo/8189927/VJH_Thumbnail_1400b48w2.jpg)
58.2K
Downloads
271
Episodes
The Video Journal of Hematology and Hematological Oncology (VJHemOnc) podcast covers the latest hematological oncology and hematology news from international experts – from leukemias, lymphomas, MDS and MPNs, to sickle cell, aplastic anemia and rare diseases. Made for healthcare professionals and researchers, we are a global, independent, open-access platform. Listen to the latest news, including cutting-edge trial updates, controversies and opinion. If you enjoy the podcast, please leave us a rating and review! For more news visit www.vjhemonc.com
Episodes
![iwAL 2022 Session III: Novel targets, combinations and treatment strategies in AML](https://pbcdn1.podbean.com/imglogo/image-logo/8189927/VJH_Thumbnail_1400b48w2_300x300.jpg)
Wednesday Nov 16, 2022
iwAL 2022 Session III: Novel targets, combinations and treatment strategies in AML
Wednesday Nov 16, 2022
Wednesday Nov 16, 2022
The 4th International Workshop on Acute Leukemias (iwAL) 2022 took place in Nice, France, and brought together leading experts in the field as they discussed several topics. In this podcast series, you will hear the latest updates in acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) and gain an insight into the sessions that took place at this year’s meeting.
In this podcast, Richard Stone, MD, Dana-Farber Cancer Institute, Boston, MA, David Sallman, MD, H. Lee Moffitt Cancer Center, Tampa, FL, and Thomas Cluzeau, MD, PhD, Central University Hospital of Nice, Nice, France, discuss novel targets and combinations in AML, treatment approaches for patients with TP53-mutated disease, and more.
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.